CHRS
Coherus Oncology, Inc. SEC filings
Every EDGAR filing for Coherus Oncology, Inc. (CHRS), newest first, with AI summaries and stories.
- Ticker
- CHRS
- CIK
- 1512762
- Latest filing
- Aug 28
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINE424B5Coherus Oncology, Inc.CHRSLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B5Securities offering
- 424B3Securities offering
ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINES-8Coherus Oncology, Inc.CHRSLIVE NOTABLE10-QCoherus Oncology, Inc.CHRSLIVE ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINESCHEDULE 13GCoherus Oncology, Inc.CHRSLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINE4Coherus Oncology, Inc.CHRSLIVE Ali J. Satvat, insider filing for CHRS
Ali J. Satvat, reporting
ROUTINE4Coherus Oncology, Inc.CHRSLIVE 6 insider filings
Rita A Karachun, insider filing for CHRS
Show all 6
- 4Insider filing for CHRS
- 4Insider filing for CHRS
- 4Insider filing for CHRS
- 4Insider filing for CHRS
- 4Insider filing for CHRS
- 4Insider filing for CHRS
Rita A Karachun, reporting
ROUTINE4Coherus Oncology, Inc.CHRSLIVE 2 insider filings
Bryan J McMichael, insider filing for CHRS
Show all 2
- 4Insider filing for CHRS
- 4Insider filing for CHRS
Bryan J McMichael, reporting
ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINEDEFA14ACoherus Oncology, Inc.CHRSLIVE ROUTINESCHEDULE 13G/ACoherus Oncology, Inc.CHRSLIVE Ownership stake disclosure by Timothy G. Youngquist 2020 Irrevocable Trust (amended)
Timothy G. Youngquist 2020 Irrevocable Trust, filed by
NOTABLE10-QCoherus Oncology, Inc.CHRSLIVE ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINESCHEDULE 13G/ACoherus Oncology, Inc.CHRSLIVE Ownership stake disclosure by Timothy G. Youngquist 2020 Irrevocable Trust (amended)
Timothy G. Youngquist 2020 Irrevocable Trust, filed by
ROUTINEDEFA14ACoherus Oncology, Inc.CHRSLIVE ROUTINESCHEDULE 13G/ACoherus Oncology, Inc.CHRSLIVE Ownership stake disclosure by Thomas A Satterfield Jr (amended)
Thomas A Satterfield Jr, filed by
ROUTINESCHEDULE 13G/ACoherus Oncology, Inc.CHRSLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINEARSCoherus Oncology, Inc.CHRSLIVE ROUTINEDEF 14ACoherus Oncology, Inc.CHRSLIVE ROUTINEDEFA14ACoherus Oncology, Inc.CHRSLIVE ROUTINEPRE 14ACoherus Oncology, Inc.CHRSLIVE ROUTINESCHEDULE 13G/ACoherus Oncology, Inc.CHRSLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
NOTABLE10-KCoherus Oncology, Inc.CHRSLIVE ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINE424B5Coherus Oncology, Inc.CHRSLIVE ROUTINE424B5Coherus Oncology, Inc.CHRSLIVE ROUTINESCHEDULE 13GCoherus Oncology, Inc.CHRSLIVE Ownership stake disclosure by Timothy G. Youngquist 2020 Irrevocable Trust
Timothy G. Youngquist 2020 Irrevocable Trust, filed by
ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINESCHEDULE 13G/ACoherus Oncology, Inc.CHRSLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
ROUTINE4Coherus Oncology, Inc.CHRSLIVE 2 insider filings
Dennis M Lanfear, insider filing for CHRS
Show all 2
- 4Insider filing for CHRS
- 4Insider filing for CHRS
Dennis M Lanfear, reporting
ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINE424B5Coherus Oncology, Inc.CHRSLIVE ROUTINE4Coherus Oncology, Inc.CHRSLIVE 2 insider filings
Bryan J McMichael, insider filing for CHRS
Show all 2
- 4Insider filing for CHRS
- 4Insider filing for CHRS
Bryan J McMichael, reporting
ROUTINE8-KCoherus Oncology, Inc.CHRSLIVE ROUTINEEFFECTCoherus Oncology, Inc.CHRSLIVE ROUTINES-3Coherus Oncology, Inc.CHRSLIVE Coherus Oncology, Inc. (CHRS) has filed a Form S-3 registration statement to efficiently raise capital by offering various securities to the public.